ConductScience.org, home

Paper1348974

Intrinsic resistance to anticancer agents in the murine pancreatic adenocarcinoma PANC02.

Priebe TS and 3 others. Cancer Chemother Pharmacol, 1992. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. Intrinsic resistance to anticancer agents in the murine pancreatic adenocarcinoma PANC02. Papers, record 1348974. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1348974

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Intrinsic resistance to anticancer agents in the murine pancreatic adenocarcinoma PANC02.
PubMed
Journal
Cancer Chemother Pharmacol
PubMed
Year
1992
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
0.5
iCite
Revised in PubMed
2022-03-30
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Priebe TST S
2Atkinson ENE N
3Pan BFB F
4Nelson JAJ A

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
Antineoplastic AgentsMajor topic
Pancreatic NeoplasmsMajor topic
ATP Binding Cassette Transporter, Subfamily B, Member 1
Animals
Antipyrine
Cisplatin
Drug Resistance
Female
Inulin
Male
Mammary Neoplasms, Experimental
Membrane Glycoproteins
Mice
Mice, Inbred C57BL
Neoplasm Transplantation
RNA, Messenger

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA-16672NCI NIH HHSUnited StatesP01CA016672PubMed and NIHNIH RePORTER
CA-28034NCI NIH HHSUnited StatesR01CA028034PubMed and NIHNIH RePORTER
P30CA016672NIHNIH RePORTER

Download CSV of grants

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12911256Gene deletion, a mechanism of induced mutation by arabinosyl nucleosides.Mutat Res1989https://conductscience.org/library/papers/2911256PubMed
21913664Potentiation of mitomycin C and porfiromycin antitumor activity in solid tumor models by recombinant human interleukin 1 alpha.Cancer Res1991https://conductscience.org/library/papers/1913664PubMed
36692374Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice.Cancer Res1984https://conductscience.org/library/papers/6692374PubMed
46372991Tumor heterogeneity.Cancer Res1984https://conductscience.org/library/papers/6372991PubMed
54827349On the presence within tumours of clones that differ in sensitivity to cytostatic drugs.Acta Pathol Microbiol Scand A1974https://conductscience.org/library/papers/4827349PubMed
61568290Mechanisms of resistance to 6-thioguanine in a murine pancreatic tumor.Cancer Chemother Pharmacol1992https://conductscience.org/library/papers/1568290PubMed
73863701Correlations between anthracycline resistance, drug accumulation and membrane glycoprotein patterns in solid tumors of mice.Cancer Lett1985https://conductscience.org/library/papers/3863701PubMed
84644205Differential sensitivites of human melanoma cells grown in vitro to arabinosylcytosine.Cancer Res1972https://conductscience.org/library/papers/4644205PubMed
93681376Intrinsic drug resistance in human kidney cancer is associated with expression of a human multidrug-resistance gene.J Clin Oncol1987https://conductscience.org/library/papers/3681376PubMed
103464801Sensitivity of proliferating cultured murine pancreatic tumor cells to selected antitumor agents.J Natl Cancer Inst1986https://conductscience.org/library/papers/3464801PubMed
116807556Metabolism and mechanisms of action of 9-(tetrahydro-2-furyl)-6-mercaptopurine in Chinese hamster ovary cells.Chem Biol Interact1982https://conductscience.org/library/papers/6807556PubMed
123391810Decreased bone growth arrest in weanling rats with multiple radiation fractions per day.Int J Radiat Oncol Biol Phys1988https://conductscience.org/library/papers/3391810PubMed
132652316Therapeutic implications of tumor heterogeneity.Semin Oncol1989https://conductscience.org/library/papers/2652316PubMed
146961973Role of the host in the variable chemotherapeutic response of advanced Ridgway osteogenic sarcoma.Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/6961973PubMed
152885085Multidrug resistance.Cancer Surv1986https://conductscience.org/library/papers/2885085PubMed
167248979Biological and experimental consequences of the zonal composition of solid tumors.Cancer Res1981https://conductscience.org/library/papers/7248979PubMed
176313211Identification of two distinct regulatory regions adjacent to the human beta-interferon gene.Cell1983https://conductscience.org/library/papers/6313211PubMed
18518835Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.Biochemistry1979https://conductscience.org/library/papers/518835PubMed
192122232Overexpression of the multidrug resistance gene mdr3 in spontaneous and chemically induced mouse hepatocellular carcinomas.Mol Cell Biol1990https://conductscience.org/library/papers/2122232PubMed

Download CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
37461129Intratumoral IL15 Improves Efficacy of Near-Infrared Photoimmunotherapy.Mol Cancer Ther2023https://conductscience.org/library/papers/37461129PubMed
37244938Myeloid MyD88 restricts CD8+ T cell response to radiation therapy in pancreatic cancer.Sci Rep2023https://conductscience.org/library/papers/37244938PubMed
37072485Tumor resident memory CD8 T cells and concomitant tumor immunity develop independently of CD4 help.Sci Rep2023https://conductscience.org/library/papers/37072485PubMed
36056093ICOS is upregulated on T cells following radiation and agonism combined with radiation results in enhanced tumor control.Sci Rep2022https://conductscience.org/library/papers/36056093PubMed
33816320Defining Immunogenic and Radioimmunogenic Tumors.Front Oncol2021https://conductscience.org/library/papers/33816320PubMed
31727378Shear Wave Elastography Can Differentiate between Radiation-Responsive and Non-responsive Pancreatic Tumors: An ex Vivo Study with Murine Models.Ultrasound Med Biol2020https://conductscience.org/library/papers/31727378PubMed
30726287Blockade of fibroblast activation protein in combination with radiation treatment in murine models of pancreatic adenocarcinoma.PLoS One2019https://conductscience.org/library/papers/30726287PubMed
30584324A peptide-CpG-DNA-liposome complex vaccine targeting TM4SF5 suppresses growth of pancreatic cancer in a mouse allograft model.Onco Targets Ther2018https://conductscience.org/library/papers/30584324PubMed
27602953Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy.Oncotarget2016https://conductscience.org/library/papers/27602953PubMed
23936036The peripheral myeloid expansion driven by murine cancer progression is reversed by radiation therapy of the tumor.PLoS One2013https://conductscience.org/library/papers/23936036PubMed
22761754Expression of NF-κB p50 in tumor stroma limits the control of tumors by radiation therapy.PLoS One2012https://conductscience.org/library/papers/22761754PubMed
20405291cis-Hydroxyproline-mediated pancreatic carcinoma growth inhibition in mice.Int J Colorectal Dis2010https://conductscience.org/library/papers/20405291PubMed
11558631A novel, clinically relevant animal model of metastatic pancreatic adenocarcinoma biology and therapy.Int J Pancreatol2001https://conductscience.org/library/papers/11558631PubMed
9764577Tau expression in model adenocarcinomas correlates with docetaxel sensitivity in tumour-bearing mice.Br J Cancer1998https://conductscience.org/library/papers/9764577PubMed
1568290Mechanisms of resistance to 6-thioguanine in a murine pancreatic tumor.Cancer Chemother Pharmacol1992https://conductscience.org/library/papers/1568290PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1348974

GET https://conductscience.org/api/papers/v1/1348974/authors